ProQR (PRQR) – New Coverage
-
Cantor Fitzgerald Maintains ProQR Therapeutics N.V. (PRQR) at Overweight with $3.50 Price Target
-
UPDATE: Raymond James Starts ProQR Therapeutics N.V. (PRQR) at Strong Buy
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PRQR Stock Lookup